Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment by Perez-Molina, JA et al.
POSTER PRESENTATION Open Access
Response to HAART according to sex and origin
(immigrant vs autochthonous) in a cohort of
patients who initiate antiretroviral treatment
JA Perez-Molina
1*, M Mora-Rillo
2, I Suarez-Lozano
3, JL Casado
4, R Teira
5, P Rivas
6, E Pedrol
7, A Hernando
8,
P Domingo
9, E Barquilla
10, H Esteban
10, J Gonzalez-Garcia
10
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Purpose
Although poorly studied, gender differences can affect
the efficacy of HAART. Immigrant women (IW) may
also be at risk of treatment failure due to greater mar-
ginalization, cultural differences, or reduced access to
health care. This subanalysis examined differences in
baseline characteristics and response to HAART accord-
ing to sex and geographic origin.
Methods
Subanalysis of GES-5808 (retrospective comparative
study autochthonous/immigrant patients initiating
HAART Jan05-Dec06). Late diagnosis was defined as a
CD4+ count ≥200, and/or AIDS at initiation of HAART.
The primary endpoint was time to treatment failure
(TTF), which was defined as virological failure (VF),
death, opportunistic infection (OI), interruption of
HAART, or loss to follow-up. Survival was analyzed
using a univariate (Kaplan-Meier) and multivariate (Cox
regression) approach.
Results
Patient Characteristics at Initiation of HAART
(Table 1)
Conclusions
Response to HAART was similar in both sexes. Men
started HAART later and women had higher loss to
follow-up and more treatment switches. This was even
more common among IW. Earlier diagnosis is necessary
for men; measures to improve adherence should be pro-
moted among women, especially IW.
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Table 1
WOMEN (318) MEN (772) P
Immigrants, % 45.6 31.1 <0.001
Age, years (IQR) 35 (29-41) 39 (33-44) <0.001
Median viral load (IQR)/CD4 (IQR) 4.7 (4.2-5.2)/ 217 (113-300) 5.0 (4.5-5.4)/ 190 (69-280) 0.001/0.002
Coinfection with HBV or HCV % 25.2 29.3 0.32
Stage C/Late diagnosis, % 21.2/49.0 29.0/59.0 0.006/0.003
Median time from diagnosis of HIV infection to initiation of HAART, mo (IQR) 15 (2-43) 16 (2-49) 0.55
Median TTF, wk 147 171 <0.001
VF/OI, % 5.3 6.3 0.52
Educational level and occupational status were significantly poorer in women. The adjusted risk of treatment failure in women was not significantly different
from that of men (HR, 1.101; 95% CI, 0.79-1.53). The increase in CD4 lymphocytes was equivalent (185 vs 205). TTF was shorter among (IW) than autochthonous
women (AW): 124 weeks (95% CI, 64-183) vs 152 (95% CI, 127-174). Most immigrant women were African and Latin American, and their dropout rate (25.5 vs
11.6) was double that of AW.
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